equities

UnitedHealth and Humana slide after CMS proposes $90 billion anti-fraud rule

Published November 19, 20264 min read
Unmarked medical-record folders sit in an open filing cabinet beside a stethoscope.
Medical-record documentation is central to the Medicare Advantage payment audits CMS proposes to strengthen. Illustration: MarketIntelLabs

The Centers for Medicare and Medicaid Services proposed a sweeping payment-integrity and anti-fraud rule on Nov. 16 that it says would save nearly $90 billion over the next decade, and the managed-care stocks it targets fell sharply in the two sessions that followed, dragging the Dow.

The proposal is the rulemaking arm of the administration's CRUSH initiative, for Comprehensive Regulations To Uncover Suspicious Healthcare, first floated as a Federal Register request for information in February. It is a standalone, discretionary rule designed to strengthen program integrity, and it reaches across Medicare, Medicaid, the Children's Health Insurance Program and the federal health insurance Marketplace. CMS filed the proposed rule with the Federal Register on Nov. 16 as CMS-6098-P, and comments are due Jan. 19, 2027, which is the next dated catalyst before any final rule.

Related reading: Costco declares $30 special dividend, its first in nearly three years.

The provision with the largest financial consequence sits in Medicare Advantage, the government-run, privately delivered Medicare option that is the managed-care sector's biggest and most profitable franchise. The rule would strengthen the Risk Adjustment Data Validation (RADV) audits that reconcile what plans are paid. CMS would identify and recover improper payments when diagnosis data an MA organization submits to support risk-adjusted payments is not backed by medical record documentation and has improperly inflated beneficiary risk scores. Because MA plans are paid on a risk-adjusted per-member basis, higher risk scores mean higher revenue, so audit findings that claw back unsupported coding hit revenue and margins directly.

Other Medicare provisions would require MA organizations and Part D plan sponsors to report suspicious or substantiated fraud, waste and abuse to CMS, require certain MA plan providers and suppliers to enroll in Original Medicare so CMS can screen their credentials, give CMS stronger authority to deny or revoke enrollment where a provider's owners cannot be confirmed, require providers to report enrollment changes within 30 days, and strengthen protections for seniors against unsolicited texts, emails and door-to-door visits from medical supply agents.

Related reading: Nvidia Q3 earnings explained: who pays for AI growth?.

The rule also tightens fee-for-service Medicare and Medicaid: stronger provider screening and enrollment safeguards, prompt self-reporting and return of identified overpayments, more managed-care program-integrity reporting, greater provider-ownership transparency, and stricter scrutiny of deductions from Medicaid payments. Marketplace provisions would bar agents and brokers with felony convictions and add suspension and termination authority.

The market read the proposal as a direct threat to risk-adjustment revenue. UnitedHealth closed at $349.91 on Nov. 18, down 5.4% on Nov. 17 and 10.2% on Nov. 18, a two-session fall of about 15% from its $412.02 close on Nov. 16. Humana lost 3.9% then 13.0%, down about 16% over the two sessions to $385.78. Elevance closed at $400.84, off roughly 10% over the two sessions, and CVS, whose Aetna unit is one of the largest MA carriers, closed at $81.35, down about 8%. The SPDR Dow Jones ETF, a proxy for the Dow Jones Industrial Average, fell about 2.7% over the two sessions, closing at $501.73 on Nov. 18, with UnitedHealth, a Dow member trading near the top of the index's price range, taking an outsized toll on the price-weighted average.

Related reading: Disney earnings: $3B savings, streaming and parks.

CMS frames the rule as protecting the Medicare trust funds. Agency data in the Nov. 16 release put program-integrity recoveries at a record $41.9 billion in fiscal 2025, up 59% from $26.3 billion in fiscal 2024, with a return on investment of $22.30 per dollar spent. The $90 billion figure is the agency's own estimate of taxpayer savings over 10 years, not a guaranteed result, and the rule is a proposal that will be revised before it is finalized.

The near-term earnings risk for insurers is real but depends on how aggressively the final rule expands audit scope, whether audit findings are extrapolated across a plan's book, and how much of the clawback can be appealed. That uncertainty, not a set of specific write-downs, is what drove the two-day selloff. Managed care has argued in past RADV disputes that audits double-count legitimate coding and that Medicare Advantage overpayment estimates are overstated, and it will press that case in the comment period. If final audits are narrower, much of the feared impact may not materialize.

Related reading: Nvidia halts China AI chip sales as US export rule expands.

Who gains and who pays: taxpayers gain whatever savings materialize, and Medicare Advantage beneficiaries gain the new anti-fraud protections, at least on paper. The risk for beneficiaries is that plans pass tighter audit exposure back in the form of thinner benefits, higher premiums or exit from counties, which would shrink choice. The comment period, closing Jan. 19, 2027, is where those trade-offs get fought out, and the final rule, likely months later, will set the audit terms the sector actually lives with.

This content is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Consult a qualified financial advisor before making investment decisions.

Get daily intelligence delivered

Create a free account for the Daily Brief every weekday and The Week Ahead every Sunday. No card required.